Vanda Pharmaceuticals
VNDA
VNDA
125 hedge funds and large institutions have $621M invested in Vanda Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
-12
Holders Change %
-8.76%
% of All Funds
2.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
49
Reduced
42
Closed
25
Calls
$768K
Puts
$9.36M
Net Calls
-$8.59M
Net Calls Change
-$13.9M
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$40.7M |
| 2 |
SCM
2
Stonepine Capital Management
Bend,
Oregon
|
$13.5M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$32.5M |
| 4 |
ACA
4
Avoro Capital Advisors
New York
|
$21.4M |
| 5 |
5
Macquarie Group
Sydney, NSW 2000,
Australia
|
$34.5M |
